Company Filing History:
Years Active: 2024-2025
Title: Dorit Mimrod: Innovator in Esketamine Administration
Introduction
Dorit Mimrod is a notable inventor based in Jerusalem, Israel. She has made significant contributions to the field of medicine, particularly in the treatment of major depressive disorder. With a total of 2 patents, her work focuses on improving the administration of esketamine, a critical medication for mental health.
Latest Patents
Mimrod's latest patents include innovative methods for the safe and efficacious administration of esketamine. The first patent outlines a dosage regime specifically designed for treating major depressive disorder. The second patent similarly provides methods for the effective administration of esketamine, emphasizing safety and efficacy in treatment.
Career Highlights
Dorit Mimrod is currently associated with Clexio Biosciences Ltd., where she continues to advance her research and development efforts. Her work is pivotal in enhancing treatment options for patients suffering from major depressive disorder.
Collaborations
Mimrod collaborates with Johanna Schumann, who is also a key figure in their research endeavors. Together, they work towards innovative solutions in the field of mental health.
Conclusion
Dorit Mimrod's contributions to the medical field, particularly through her patents on esketamine administration, highlight her role as an influential inventor. Her ongoing work promises to improve treatment outcomes for individuals with major depressive disorder.